Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/1991
11/06/1991EP0455155A1 Separation of cimaterol enantiomers
11/06/1991EP0455093A2 Use of a tumor necrosis factor for facilitating nerve regeneration
11/06/1991EP0454818A1 Method for the preparation and purification of a mixture of glycosphingolipids free from contamination by non-conventional viruses
11/06/1991CN1055929A 2,9-disubstituted-4h-pyrido (1,2-a) pyrimidin-4-ones
11/05/1991US5063231 Gastrointestinal
11/05/1991US5063060 Compositions and method for treating painful, inflammatory or allergic disorders
11/05/1991CA1291766C Pharmaceutical compositions for the therapy of cerebropatheis on functional and organic base
11/05/1991CA1291758C Derivatives of 3-imino-pyridazine, process for obtaining them and pharmaceutical compositions containing them
11/05/1991CA1291754C Fused five-ring heterocyclic compounds, their production, and their pharmaceutical use
11/02/1991WO1991017242A1 Human neuronal cell line
11/02/1991CA2081976A1 Human neuronal cell line
10/1991
10/31/1991WO1991016437A1 Soluble peptide analogues containing binding sites
10/31/1991WO1991016355A1 Method for increasing blood-brain barrier permeability
10/31/1991WO1991016307A1 3-indolyl thioacetate derivatives
10/31/1991CA2081308A1 Method for increasing blood-brain barrier permeability
10/31/1991CA2081207A1 Soluble peptide analogues containing binding sites
10/31/1991CA2041462A1 Ethanobicyclic amine derivatives for cns disorders
10/30/1991EP0454617A1 Treatment of sinus headache
10/30/1991EP0454511A1 N-substituted heterocycle derivatives, their preparation, compositions containing them
10/30/1991EP0454436A1 Pharmaceutical compounds
10/30/1991EP0454121A2 Azatetracyclic compounds
10/30/1991EP0454102A2 Essential fatty acid compositions
10/30/1991EP0454089A1 Percutaneously absorbable eperisone or tolperisone preparation
10/30/1991EP0453515A1 Composition for treatment of senile dementia
10/30/1991EP0179808B1 Pharmaceutical composition suitable for treatment or prophylaxis of cardiac disorders
10/30/1991CN1055741A Ganglioside derivatives
10/30/1991CN1014519B Process for preparation of 5-naphthyl-2, 4-dialkyl-3h-1, 2, 4-triazoie-3-thiones and their use as antidepressants
10/29/1991WO1991017116A1 Novel 1-(2h-1-oxo-3,4-dihydronaphtyl-6)-acetyl-piperidines, process for their preparation and therapeutic use
10/29/1991US5061728 Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of inflammation and as immunosuppressants
10/29/1991US5061725 Cognition activators
10/29/1991US5061721 Side effect reduction
10/29/1991US5061713 No antiinflammatory activity
10/29/1991US5061706 2,3-quinoxalinediones for use as neuroleptics
10/29/1991US5061703 Alzheimer*s disease
10/29/1991CA2081351A1 1-(2h-1-oxo-3, 4-dihydronaphtyl-6) -acetyl-piperidines, process for their preparation and therapeutic use
10/29/1991CA1291592C Peptide antagonists of neurokinin b
10/29/1991CA1291484C 6-substituted-4-dialkylaminotetrahydrobenz¬c,d|indoles
10/28/1991WO1991017161A1 Isoquinoline amides and esters as 5 ht3 receptor antagonists
10/28/1991WO1991016819A1 Method and composition for treatment of central nervous systems disease states associated with abnormal amyloid beta protein
10/28/1991CA2081350A1 Isoquinoline amides and esters as 5 ht3 receptor antagonists
10/25/1991WO1991016325A1 Heterocyclic compounds and their preparation and use
10/25/1991CA2081201A1 Heterocyclic compounds and their preparation and use
10/24/1991CA2040965A1 Pharmaceutical compositions comprising tnf for induction of nerve regeneration
10/23/1991EP0453242A1 Transfer and expression of gene sequences into central nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication
10/23/1991EP0453042A1 Novel 2,9-disubstituted-4H-pyrido-[1,2-a]pyrimidin-4-ones
10/23/1991EP0452926A2 5-aryl-4-alkyl-3H-1,2,4-triazole-3-thiones useful as memory enhancers
10/23/1991EP0452850A1 4-[3-(4-Oxothiazoldinyl)]butynylamines, a process for their preparation and their use as medicaments
10/23/1991EP0452765A2 Pharmaceutical composition and medical uses of dioxopiperidine derivatives, especially as immune response potentiators, antiviral and antibacterial agents
10/23/1991EP0452390A1 Halo substituted aminotetralins.
10/23/1991EP0418230A4 Method for potentiating and inhibiting insulin-like growth factor activity
10/23/1991CN1055537A 3,5-disubstituted-2-isoxazolines, process for their preparation, agents containing them and their use
10/23/1991CN1014409B Manufacturing process for asscorbic acid derivative
10/22/1991US5059627 For mammals suffering from degenerative nervous system disorders
10/22/1991US5059612 Rolipram
10/22/1991US5059608 Bicyclic amine compound and a process for the preparation thereof
10/22/1991US5059607 Imidazolyl benzisoquinolines useful as 5-ht3 receptor antagonists
10/22/1991US5059602 4-substituted dihydropyrido(4,3-d)pyrimidines as analgesics and topical antiinflammatory agents for the treatment of skin disorders
10/22/1991US5059601 Imidazolone derivatives with activity on central nervous system and antihypertensive activity, preparation methods thereof, and pharmaceutical compositions containing them
10/22/1991US5059599 Derivatives of 1-phenyl 1,4-dihydro 3-amino 4-oxo pyridazines, their preparation and their use in therapy
10/22/1991US5059595 Pharmaceutical compositions containing 5-methyltetrahydrofolic acid, 5-formyltetrahydrofolic acid and their pharmaceutically acceptable salts in controlled-release form active in the therapy of organic mental disturbances
10/22/1991US5059594 Phytic acid compositions
10/22/1991US5059427 Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or salt thereof
10/22/1991CA1291133C Optically active 2-chloro-12-(3-dimethylamino-2- methylpropyl)-12h-dibenzo ¬d,g| ¬1,3,6| dioxazocines and a process for the preparation thereof
10/22/1991CA1291121C 12- and 13-bromoergoline derivatives
10/22/1991CA1291119C 2-substituted ergoline derivatives, processes for their preparation and use thereof as medicinal agents
10/22/1991CA1291044C Spray dried acetaminophen
10/18/1991WO1991016306A1 An improved process for the preparation of substituted indolone derivatives
10/18/1991CA2031994A1 Injectable formulations containing the sodium salt of naproxen
10/17/1991WO1991015468A1 Novel compound
10/17/1991WO1991015225A1 Multiple sclerosis t-cell receptor
10/17/1991WO1991008298A3 Fusion proteins consisting of a ligand binding protein and a stable plasma protein
10/17/1991CA2039921A1 Transfer and expression of gene sequences into central nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication
10/16/1991EP0452204A1 3-Aminochromane derivatives, procedure for their preparation and pharmaceutical compositions containing them
10/16/1991EP0452170A1 1,2,5,6-Tetrahydropyridin-3-carboxaldehyde oxime derivatives, process for their preparation and their use as drugs
10/16/1991EP0452101A2 Spiro bridged and unbridged heterocyclic compounds
10/16/1991EP0452074A2 Ergoline-8-carboxamides for blocking 5HT receptors
10/16/1991EP0451880A2 An ex vivo tissue perfusion composition and the use thereof
10/16/1991EP0451790A1 3,5-disubstituted 2-isoxazolines and isoxazoles, process for their preparation, medicines containing them and their use
10/16/1991EP0451626A2 The use of benzodiazepine compounds for preparing a pharmaceutical composition against CNS disorders related to the excitatory aminoacids
10/16/1991EP0451547A1 1,4,8-Triazacyclotridecane derivatives having prolyl endopeptidase inhibiting activity
10/16/1991EP0451538A2 Use of pyridoindole derivatives in the treatment of ischemic disorders
10/16/1991EP0451484A1 Deprenyl/L-dopa/carbidopa pharmaceutical composition
10/15/1991US5057605 Sialocylglycerolipids and method for preparing the same
10/15/1991US5057516 Nervous system disorders
10/15/1991US5057324 Kallikrein inhibitor substance, a process for preparation and pharmaceutical compositions thereof
10/14/1991CA2040242A1 Treatment with benzodiazepine compounds
10/13/1991CA2040219A1 3,5-disubstituted 2-isoxazolines and isoxazoles, processes for their preparation, agents containing them and their use
10/12/1991WO1991015194A1 Taste masking of ibuprofen by fluid bed coating
10/12/1991CA2076983A1 Taste masking of ibuprofen by fluid bed coating
10/12/1991CA2040170A1 Ergoline-8-carboxamides
10/11/1991WO1991015507A1 Phosphonopeptides with collagenase inhibiting activity
10/11/1991CA2080227A1 Phosphonopeptides with collagenase inhibiting activity
10/10/1991CA2039937A1 3-aminochroman derivatives, their preparation process and pharmaceutical compositions containing them
10/09/1991EP0451022A1 Novel compounds for the treatment of migraine
10/09/1991EP0451009A2 Pharmaceutical composition comprising opiate antagonists for the treatment of emotional numbness
10/09/1991EP0451008A1 8-Sulfamylmethylene-2-amino tetralins
10/09/1991EP0450936A1 Monoclonal antibody to avermectins
10/09/1991EP0450757A2 Use of 5-hydroxytryptamine-antagonists in the treatment of mental disorders originating in childhood
10/09/1991EP0450508A2 Use of dermatan sulphate for the prevention and therapy of cerebral aging and of central nervous system functional deficit states
10/09/1991EP0450386A2 Production of biologically active, recombinant members of the NGF/BDNF family of neurotrophic proteins
1 ... 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 ... 1833